The adenosine A2A receptor (A2AR) is a prototypical and ubiquitous class A receptor, of interest in the pharmacological treatment of specific cardiovascular disorders, immune response and wound repair, cancer, and central nervous system disorders [82,83,84,85]. Here, ADORA2A is linked to cancer.